MR users present benefits of Esaote MRI to UKIO’s virtual attendees

Ultrasound and MR system manufacturer Esaote was among the exhibitors at UKIO’s online congress in June and approached the event with great enthusiasm, as UK country manager Nicky Mills explained: “We have a lot to say about our products and if doing it over the internet is the way forward, we decided to give it our best.”

With the impact of COVID-19 on radiology meetings, the virtual world has come into its own, says Esaote. Manufacturers and suppliers are not able to present their products and services directly to the market to assess their impact and gauge future business. Meeting organisers have quickly adapted available formats to bridge the gap between customer and supplier.

Highlights of the Esaote offering at UKIO were two webinar presentations by noted MR users from NHS trusts. Focusing on the benefits of MRI in the hospital environment, the presentations highlighted the possibility of cutting waiting lists and enabling cost savings to the NHS. ‘Initial experiences of an extremity MRI scanner’ was presented by Royal Bournemouth Hospital superintendent radiographer, CT and MRI, Matthew Benbow, while ‘Maximising the benefits of the Esaote O-scan’ was delivered by Derriford Hospital advanced practitioner radiographer Tim Relf.

Esaote regional ultrasound and MRI sales account manager John Manchester said: “We were really surprised and pleased at how well the presentations went, especially the reaction to just how small a space our MR systems are suited to and how well they cope with the increased demand in MR imaging, at the same time offering excellent image quality.”

Picture: Royal Bournemouth Hospital superintendent radiographer, CT and MRI, Matthew Benbow (left) and Derriford Hospital advanced practitioner radiographer Tim Relf each delivered webinars at UKIO.

Published on page 26 of the September 2020 issue of RAD Magazine.

You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more